Oral Appliance Maker ProSomnus Reports Record Revenue for 2023
The company reported a 43% increase in annual revenue for 2023, driven in part by greater adoption of its oral appliance therapy for obstructive sleep apnea.
The company reported a 43% increase in annual revenue for 2023, driven in part by greater adoption of its oral appliance therapy for obstructive sleep apnea.
UnitedHealthcare’s updated medical policy for obstructive and central sleep apnea establishes oral appliance therapy as a prerequisite therapy for surgical treatment in adult patients with moderate to severe OSA.
Not only does suggesting a particular oral appliance treats sleep apnea better than other appliances sound like marketing rhetoric, but it also endangers the credibility of oral appliances as a therapeutic modality.
Dog eat your patient’s oral appliance? A few simple solutions can protect your patients’ sleep apnea therapy investments.
Read MoreThe increasing demand for ProSomnus’ precision devices is buttressed by new clinical data supporting the effectiveness of the therapy, according to the company’s CEO.
Read MoreProSomnus announced plans to design a head-to-head clinical trial comparing its precision oral appliance therapy and hypoglossal nerve stimulation in treating patients with severe OSA.
Read MorePeople with obstructive sleep apnea have an increased risk of cardiovascular diseases. Researchers investigate whether oral appliance therapy can alleviate the burden.
Read MoreA national survey of 1,000 adults identified the major obstacles to treating snoring and obstructive sleep apnea.
Read MoreProSomnus presented data at two recent conferences that it says further validate precision oral appliance therapy for the treatment of obstructive sleep apnea.
Read MoreProSomnus’ CEO says the record quarter reflects growing acceptance of its precision medical devices as a solution for sleep apnea treatment.
Read MoreDental sleep medicine practitioners can help senior adults who want to use their Medicare benefits overcome common therapy challenges.
Read MoreThe study also found the device to be more effective in mild to moderate and severe OSA patients compared to traditional oral appliance therapy.
Read MoreThe data will be presented in oral and poster presentations at the 2023 American Academy of Dental Sleep Medicine Annual Meeting, being held from May 19 to 21 in Philadelphia.
Read MoreThe patent adds to a portfolio of several issued patents covering ProSomnus’ iterative titration technology in its oral appliance therapy devices.
Read MoreProsomnus’ oral devices are precision-manufactured with twin-mated posts and digitally milled to be patient-specific, according to the company.
Read MoreThe study measures treatment effectiveness as the product of therapeutic efficacy and nightly compliance.
Read MoreA peer-reviewed study in Military Medicine found that 88% of obstructive sleep apnea (OSA) patients were successfully treated using oral appliances.
Read More